Search

The article presents the findings of a study where the anti-viral drug remdesivir was used for the treatment of COVID-19. The results of the double-blind, randomized controlled trial found that individuals taking intravenous remdesivir had a shorter COVID-19 recovery time than those who received the placebo.

Pharmaceutical firm, Searle Company Limited said it finalised a deal to import Remdesivir, an antiviral drug, from Bangladesh. In a bourse filing, the company said it has partnered with Beximco Pharmaceuticals of Bangladesh to provide an immediate supply of Remdesivir at an affordable price, helping healthcare providers in Pakistan to treat hospitalised COVID-19 patients. Bangladesh-based Beximco Pharmaceuticals Limited recently announced the launch of Remdesivir, under the brand name Bemsivir, an antiviral drug, which has been recently granted Emergency Use Authorization by the US Food and Drug Administration for the treatment of COVID-19. [Extracted from the article]